Literature DB >> 19854811

Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors.

K Baker1, J Pope, P Fortin, E Silverman, C Peschken.   

Abstract

Our objectives were to examine the prevalence of work disability (WD) and factors associated with job loss in systemic lupus erythematosus (SLE) in a large, multi-centered Canadian sample to determine the current prevalence of WD and identify the contribution of disease activity, damage, and co-morbidities with respect to WD in this cohort. Cross-sectional data on WD status from the 1000 Canadian Faces of Lupus database (a multi-center multi-ethnic cohort of SLE patients) along with clinical measures (number of ACR criteria ever, SLICC Damage Index, SLAM, SLEDAI, SF-36 and Charlson Co-morbidity Index scores), demographic features (age, sex, high school education, household income, marital status, disease duration, employment status) and co-morbidities (including self-reported fibromyalgia, arthralgias, depression and fatigue) were used in bivariate and logistic regression analyses. The 1137 SLE patients had a mean age of 50 years (SE 0.75) and mean disease duration was 18 years (SE 0.70); 19.09% were work disabled and 49.78% were employed. Those with WD were more likely than non-WD SLE patients to have: a higher number of ACR criteria for SLE; not completed high school; older age; single marital status; a lower household income; longer disease duration; higher SLICC Damage Index and SLAM scores; lower SF-36 PCS and SF-36 MCS scores; less vigorous activity per week; and fibromyalgia, arthralgias, fatigue and depression (p < 0.05). This contemporary rate of WD is lower than many past reports. Socio-demographic factors, co-morbidities (fibromyalgia and fatigue) and disease related factors were strongly associated with WD. We cannot determine cause and effect as the study was cross-sectional.

Entities:  

Mesh:

Year:  2009        PMID: 19854811     DOI: 10.1177/0961203309345784

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  25 in total

1.  Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.

Authors:  Laura J Julian; Chris Tonner; Ed Yelin; Jinoos Yazdany; Laura Trupin; Lindsey A Criswell; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

2.  Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.

Authors:  Xia Xie; Dongmei Wu; Hong Chen
Journal:  Rheumatol Int       Date:  2016-08-31       Impact factor: 2.631

Review 3.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

4.  Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus.

Authors:  Laura J Julian; Steven E Gregorich; Chris Tonner; Jinoos Yazdany; Laura Trupin; Lindsey A Criswell; Ed Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

Review 5.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

6.  Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; Laura Trupin; Stuart A Gansky; Maria Dall'era; Edward H Yelin; Lindsey A Criswell; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

7.  Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.

Authors:  Pia Elfving; Kari Puolakka; Vappu Rantalaiho; Hannu Kautiainen; Lauri J Virta; Oili Kaipiainen-Seppänen
Journal:  Clin Rheumatol       Date:  2018-03-14       Impact factor: 2.980

Review 8.  [Overcoming disease in systemic lupus erythematosus].

Authors:  M Schneider; M Haupt
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

Review 9.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02

10.  Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.

Authors:  Courtney Hoge; C Barrett Bowling; S Sam Lim; Cristina Drenkard; Laura C Plantinga
Journal:  J Rheumatol       Date:  2020-03-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.